Twice-Yearly PrEP Med Passes Phase 3 Trial + More News

Some news items you might have missed: • LGBTQ Nation: Gilead has announced that its new twice-yearly pre-exposure prophylactic (PrEP) injectable medication, lenacapavir, has passed a Phase III clinical trial finding the medication protected patients from HIV in 100% of cases.Instagram: Out Olympic silver medalist Gus Kensworthy dropped some thirsty pics of his “he/she/they-nanigans” at NY Pride. https://www.instagram.com/p/C9DGYOdIpgn/ • Queerty: A question on the AskGayBrosOver30 subreddit has prompted hundreds of replies and got many older guys thinking. “What are some things you could get away with when you were younger, but can’t now that you are older?” • Netflix: Check out the official trailer for the eighth and final season of the steamy drama Élite. The hit series debuted in 2018 and revolves around three working class students who won scholarships to a prestigious private school. The trailer promises lots of drama, maybe a murder mystery and some hot guys in homoerotic encounters. Fox 2 Detroit: Under an approved bill headed to Michigan Gov. Gretchen Whitmer’s desk, it would no longer be legal to argue that someone’s sexual orientation justified assaulting them. Michigan would become the 20th state in the country to ban so-called “gay panic” defense. • New Music: Rising pop/country artist Amanda McCarthy spills the tea, or rather, the vodka, with her latest single “Vodka,” exploring the unpredictable truths that come tumbling out after a few too many drinks – from revealing her place in the LGBTQ+ community to dishing out baby daddy drama and high school trauma. https://youtu.be/3vsu4ERrd9s?si=dyEs4iLTo6fo6Bpn


Discover more from The Randy Report

Subscribe to get the latest posts sent to your email.

Share via
Copy link